Reduced responsiveness of the reward system underlies tolerance to cannabis impairment in chronic users

Published on Jul 19, 2019in bioRxiv
· DOI :10.1101/708677
Natasha L. Mason3
Estimated H-index: 3
(UM: Maastricht University),
Eef L. Theunissen21
Estimated H-index: 21
(UM: Maastricht University)
+ 5 AuthorsJohannes G. Ramaekers41
Estimated H-index: 41
(UM: Maastricht University)
Cannabis is the most commonly used illicit drug in the world. However due to a changing legal landscape, and rising interest in therapeutic utility, there is an increasing trend in (long-term) use and possibly, cannabis impairment. Importantly, a growing body of evidence suggests regular cannabis users develop tolerance to the impairing, as well as the rewarding, effects of the drug. However, the neuroadaptations that may underlie cannabis tolerance remain unclear. Therefore, this double-blind, randomized, placebo controlled, cross-over study assessed the acute influence of cannabis on brain and behavioral outcomes in two distinct cannabis user groups. Twelve occasional (OUs) and 12 chronic (CUs) cannabis users received acute doses of cannabis (300 μg/kg THC) and placebo, and underwent ultra-high field functional magnetic resonance imaging (fMRI) and magnetic resonance spectroscopy (MRS). In OUs, cannabis induced significant neurometabolic alterations in reward circuitry, namely decrements in functional connectivity and increments in striatal glutamate concentrations, which were associated with increases in subjective high and decreases in performance on a sustained attention task. Such changes were absent in CUs. The finding that cannabis altered circuitry and distorted behavior in OUs, but not CUs, suggests reduced responsiveness of the reward circuitry to cannabis intoxication in chronic users. Taken together, the results suggest a pharmacodynamic mechanism for the development of tolerance to cannabis impairment.
  • References (60)
  • Citations (0)
#1Sarah HartleyH-Index: 5
#2Nicolas Simon (AMU: Aix-Marseille University)H-Index: 23
Last.Jean Claude Alvarez (French Institute of Health and Medical Research)H-Index: 3
view all 7 authors...
2 CitationsSource
#1Marco Colizzi (South London and Maudsley NHS Foundation Trust)H-Index: 13
#2Nathalie Weltens (Katholieke Universiteit Leuven)H-Index: 7
Last.Sagnik Bhattacharyya (South London and Maudsley NHS Foundation Trust)H-Index: 33
view all 7 authors...
7 CitationsSource
#1Natasha L. Mason (UM: Maastricht University)H-Index: 3
#2Eef L. Theunissen (UM: Maastricht University)H-Index: 21
Last.Johannes G. Ramaekers (UM: Maastricht University)H-Index: 41
view all 7 authors...
2 CitationsSource
#1Marco Colizzi ('KCL': King's College London)H-Index: 13
#2Sagnik Bhattacharyya ('KCL': King's College London)H-Index: 33
8 CitationsSource
#1E van de Giessen (Columbia University)H-Index: 2
#2Jodi J. Weinstein (Columbia University)H-Index: 6
Last.Anissa Abi-Dargham (Columbia University)H-Index: 64
view all 13 authors...
44 CitationsSource
#1Johannes G. Ramaekers (UM: Maastricht University)H-Index: 41
#2J.H.P. van Wel (UM: Maastricht University)H-Index: 5
Last.Robbert Jan Verkes (Radboud University Nijmegen)H-Index: 21
view all 10 authors...
14 CitationsSource
#1Shirley Y. Hill (University of Pittsburgh)H-Index: 35
#2Vinod Sharma (University of Pittsburgh)H-Index: 8
Last.Bobby L. Jones (University of Pittsburgh)H-Index: 23
view all 3 authors...
7 CitationsSource
#1Michael D. Scofield (MUSC: Medical University of South Carolina)H-Index: 13
#2Jasper A. Heinsbroek (MUSC: Medical University of South Carolina)H-Index: 9
Last.Peter W. Kalivas (MUSC: Medical University of South Carolina)H-Index: 85
view all 8 authors...
113 CitationsSource
#2J.H.P. van WelH-Index: 5
Last.Robbert-J. Verkes (Radboud University Nijmegen)H-Index: 1
view all 7 authors...
18 CitationsSource
#1Eric Plitman (U of T: University of Toronto)H-Index: 14
Last.Ariel Graff-GuerreroH-Index: 33
view all 7 authors...
41 CitationsSource
Cited By0